Compare EQBK & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EQBK | IART |
|---|---|---|
| Founded | 2002 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2015 | 1996 |
| Metric | EQBK | IART |
|---|---|---|
| Price | $49.79 | $17.09 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 7 |
| Target Price | ★ $51.33 | $14.33 |
| AVG Volume (30 Days) | 74.3K | ★ 655.0K |
| Earning Date | 04-14-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.59% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.06 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $74.58 | $4.39 |
| Revenue Next Year | $5.11 | $3.40 |
| P/E Ratio | $24.14 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $38.60 | $8.70 |
| 52 Week High | $52.27 | $20.49 |
| Indicator | EQBK | IART |
|---|---|---|
| Relative Strength Index (RSI) | 43.46 | 45.78 |
| Support Level | $44.45 | $16.04 |
| Resistance Level | $50.07 | $18.78 |
| Average True Range (ATR) | 0.83 | 0.60 |
| MACD | -0.24 | -0.05 |
| Stochastic Oscillator | 31.77 | 26.83 |
Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 77 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.